RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $992,976 | +71698.7% | 1,152,212 | 0.0% | 0.05% | -17.2% |
| Q2 2023 | $1,383 | -92.6% | 1,152,212 | -46.3% | 0.06% | -93.1% |
| Q1 2023 | $18,767 | -99.9% | 2,147,212 | 0.0% | 0.92% | +1.8% |
| Q4 2022 | $17,177,696 | +199.6% | 2,147,212 | +82.7% | 0.91% | +181.4% |
| Q3 2022 | $5,734,000 | -12.2% | 1,175,000 | 0.0% | 0.32% | -22.2% |
| Q2 2022 | $6,533,000 | +9.7% | 1,175,000 | 0.0% | 0.41% | +35.3% |
| Q1 2022 | $5,957,000 | -60.6% | 1,175,000 | 0.0% | 0.31% | -48.0% |
| Q4 2021 | $15,134,000 | -13.9% | 1,175,000 | 0.0% | 0.59% | -4.2% |
| Q3 2021 | $17,578,000 | -3.7% | 1,175,000 | 0.0% | 0.61% | -4.7% |
| Q2 2021 | $18,260,000 | – | 1,175,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $7,616,000 | 1.78% |
| Cormorant Asset Management, LP | 2,326,660 | $11,354,000 | 0.79% |
| BVF INC/IL | 3,526,729 | $17,210,000 | 0.71% |
| Perceptive Advisors | 2,483,619 | $12,120,000 | 0.35% |
| Boxer Capital, LLC | 1,175,000 | $5,734,000 | 0.32% |
| UBS OCONNOR LLC | 326,451 | $1,593,000,000 | 0.03% |
| Ergoteles LLC | 65,096 | $318,000 | 0.01% |
| Lumina Fund Management LLC | 6,000 | $29,000 | 0.01% |
| Laurion Capital Management LP | 313,200 | $1,528,000 | 0.01% |
| Woodline Partners LP | 119,700 | $584,000 | 0.01% |